130 related articles for article (PubMed ID: 26829682)
21. Induction chemotherapy with docetaxel, cisplatin and S-1 followed by proton beam therapy concurrent with cisplatin in patients with T4b nasal and sinonasal malignancies.
Okano S; Tahara M; Zenda S; Fuse N; Yoshino T; Doi T; Kawashima M; Ogino T; Hayashi R; Ohtsu A
Jpn J Clin Oncol; 2012 Aug; 42(8):691-6. PubMed ID: 22761254
[TBL] [Abstract][Full Text] [Related]
22. Current management of sinonasal undifferentiated carcinoma.
Lopez F; Suárez V; Vivanco B; Suárez C; Llorente JL
Rhinology; 2015 Sep; 53(3):212-20. PubMed ID: 26363162
[TBL] [Abstract][Full Text] [Related]
23. Sinonasal Undifferentiated Carcinoma.
Abdelmeguid AS; Bell D; Hanna EY
Curr Oncol Rep; 2019 Feb; 21(3):26. PubMed ID: 30806835
[TBL] [Abstract][Full Text] [Related]
24. Induction Chemotherapy and Sequential Concomitant Chemo-radiation in Locally Advanced Head and Neck Cancers: How Induction-phase Intensity and Treatment Breaks May Impact on Clinical Outcomes.
Franco P; Potenza I; Schena M; Riva G; Pecorari G; Garzino Demo P; Fasolis M; Moretto F; Garzaro M; Di Muzio J; Melano M; Airoldi M; Ragona R; Rampino M; Ricardi U
Anticancer Res; 2015 Nov; 35(11):6247-54. PubMed ID: 26504058
[TBL] [Abstract][Full Text] [Related]
25. Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): A case-series, systematic review and meta-analysis.
Morand GB; Anderegg N; Vital D; Ikenberg K; Huber GF; Soyka MB; Egger M; Holzmann D
Oral Oncol; 2017 Dec; 75():28-34. PubMed ID: 29224819
[TBL] [Abstract][Full Text] [Related]
26. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience.
Haddad R; Colevas AD; Tishler R; Busse P; Goguen L; Sullivan C; Norris CM; Lake-Willcutt B; Case MA; Costello R; Posner M
Cancer; 2003 Jan; 97(2):412-8. PubMed ID: 12518365
[TBL] [Abstract][Full Text] [Related]
27. Clinical management of localized undifferentiated sinonasal carcinoma: our experience and review of the literature.
Perri F; Della Vittoria Scarpati G; Ionna F; Longo F; Montano M; Muto P; Ravo V; Giuliano M; Caponigro F
Anticancer Drugs; 2019 Mar; 30(3):308-312. PubMed ID: 30779722
[TBL] [Abstract][Full Text] [Related]
28. TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck.
Strojan P; Grašič Kuhar C; Žumer B; Kadivec M; Karner K; Fajdiga I; Jančar B; Gale N; Poljak M; Kocjan BJ; Zakotnik B
Head Neck; 2014 Nov; 36(11):1555-61. PubMed ID: 24123552
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial.
Korst RJ; Bezjak A; Blackmon S; Choi N; Fidias P; Liu G; Marx A; Wright C; Mock S; Rutledge JR; Keshavjee S
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):36-44, 46.e1. PubMed ID: 24139613
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
[TBL] [Abstract][Full Text] [Related]
31. Triple induction chemotherapy and chemoradiotherapy for locally advanced esophageal cancer. A phase II study.
Eisterer W; DE Vries A; Kendler D; Spechtenhauser B; Königsrainer A; Nehoda H; Virgolini I; Lukas P; Bechter O; Wöll E; Ofner D
Anticancer Res; 2011 Dec; 31(12):4407-12. PubMed ID: 22199307
[TBL] [Abstract][Full Text] [Related]
32. Weekly low-dose docetaxel-based chemoradiotherapy for locally advanced oropharyngeal or hypopharyngeal carcinoma: a retrospective, single-institution study.
Fukada J; Shigematsu N; Takeda A; Ohashi T; Tomita T; Shiotani A; Kunieda E; Kawaguchi O; Fujii M; Kubo A
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):417-24. PubMed ID: 19409727
[TBL] [Abstract][Full Text] [Related]
33. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.
Driessen CM; de Boer JP; Gelderblom H; Rasch CR; de Jong MA; Verbist BM; Melchers WJ; Tesselaar ME; van der Graaf WT; Kaanders JH; van Herpen CM
Eur J Cancer; 2016 Jan; 52():77-84. PubMed ID: 26655558
[TBL] [Abstract][Full Text] [Related]
34. Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: a phase II study.
Aydiner A; Sen F; Saglam EK; Oral EN; Eralp Y; Tas F; Toker A; Dilege S
Clin Lung Cancer; 2011 Sep; 12(5):286-92. PubMed ID: 21729649
[TBL] [Abstract][Full Text] [Related]
35. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy.
van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB
Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993
[TBL] [Abstract][Full Text] [Related]
37. Results of chemoselection with short induction chemotherapy followed by chemoradiation or surgery in the treatment of functionally inoperable carcinomas of the pharynx and larynx.
Semrau S; Schmidt D; Lell M; Waldfahrer F; Lettmaier S; Kuwert T; Iro H; Fietkau R
Oral Oncol; 2013 May; 49(5):454-60. PubMed ID: 23321550
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and prognostic factors of sinonasal undifferentiated carcinoma: a multicenter study.
de Bonnecaze G; Verillaud B; Chaltiel L; Fierens S; Chapelier M; Rumeau C; Malard O; Gavid M; Dufour X; Righini C; Uro-Coste E; Rives M; Bach C; Baujat B; Janot F; de Gabory L; Vergez S
Int Forum Allergy Rhinol; 2018 Sep; 8(9):1065-1072. PubMed ID: 29935059
[TBL] [Abstract][Full Text] [Related]
39. Definitive-intent (chemo)radiotherapy for sinonasal undifferentiated carcinoma.
Wang L; Wang J; Tang T; Yan L; Song X
Br J Radiol; 2023 Jan; 96(1141):20220244. PubMed ID: 36317997
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer.
Bae WK; Hwang JE; Shim HJ; Cho SH; Lee JK; Lim SC; Chung WK; Chung IJ
Cancer Chemother Pharmacol; 2010 Feb; 65(3):589-95. PubMed ID: 19830427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
